Mark E. Augspurger

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

Stephen G. Chun, Chen Hu, Hak Choy et al. · Journal of Clinical Oncology · 2016 · 715 citations · Full text

Randomized Clinical Trial, Surgical Oncology, Imrt Outcomes +18

Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose–volume analysis

Bin S. Teh, Barry M Uhl, Mark E. Augspurger et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 179 citations

Radiation Medicine, Radiation Therapy, Medicine +8

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227

Jon Glass, Minhee Won, Christopher J. Schultz et al. · Journal of Clinical Oncology · 2016 · 142 citations · Full text

Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme

Nathan S Floyd, Shiao Y. Woo, Bin S. Teh et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 129 citations

Neuro-oncology, Glioma, Radiation Therapy +5

Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer

Bin S. Teh, Wei-Yuan Mai, Mark E. Augspurger et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 85 citations

Adaptive Radiotherapy, Surgical Oncology, Urology +5